title: Should network biology be used for drug discovery?
authors.affiliation: a CNAG-CRG, Centre for Genomic Regulation (CRG) , Barcelona Institute of Science and Technology (BIST) , Barcelona , Spain.|b Gene Regulation, Stem Cells and Cancer Program , Centre for Genomic Regulation (CRG) , Barcelona , Spain.|c Universitat Pompeu Fabra (UPF) , Barcelona , Spain.
authors.forename: Francisco
authors.initials: F
authors.lastname: Martínez-Jiménez
authors.affiliation: a CNAG-CRG, Centre for Genomic Regulation (CRG) , Barcelona Institute of Science and Technology (BIST) , Barcelona , Spain.|b Gene Regulation, Stem Cells and Cancer Program , Centre for Genomic Regulation (CRG) , Barcelona , Spain.|c Universitat Pompeu Fabra (UPF) , Barcelona , Spain.|d ICREA, Pg. Lluís Companys , Barcelona , Spain.
authors.forename: Marc A
authors.initials: MA
authors.lastname: Marti-Renom
mesh_terms: D019295:Computational Biology / Q000379:methods*; D003198:Computer Simulation; D015195:Drug Design; D055808:Drug Discovery / Q000379:methods*; D057166:High-Throughput Screening Assays; D006801:Humans
keywords: In-silico drug discovery; computational target identification; hit identification; network biology